PDCD1 and colorectal carcinoma: An increased NK-cell mediated cytotoxic activity obtained by blocking the inhibitory receptor PD-1 upexpressed on NK-cells of patients with several solid tumors including CRC [52] was also associated with a durable cancer regression [3].